OpenVSafe by OpenVAERS
Search V-safe

Z86-18194-21227

2 vaccinations 3 coded responses 21 check-ins 3 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
295 / SC
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-14
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-22
    Survey response — day 7, dose 1
    MedDRA: Urticaria — Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection site
    Free text: Rash more like Hives
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-28
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  13. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fever · None
    Adult check-in
  16. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-05
    Survey response — 3 months, dose 2
    MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Developed a rash 7 days after 2nd shot and still have recurring problems. Dermatologist is stumped. Using multiple steroid creams and Dupixant shots. · Healthcare visit (other): Bi-weekly dermatology office visits
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-05-05
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-08-04
    Survey response — 6 months, dose 2
    MedDRA: Blister, Dermatitis, Hypersensitivity, Office visit, Rash — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continued accurate dermatitis as allergic reaction to the Pfizer shot in February. Still severe raw blisters appearing on both hands and uncontrollable rash in legs. Dermatologist is baffled as to how to treat.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-04
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-08-12
  28. 2021-08-12
  29. 2021-08-17
    Call successful
    Participant prefers to complete VAERS report online
  30. 2021-08-17
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Pfizer-BioNTech
22021-02-03Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-05-05 Successful
2021-08-17
Participant prefers to complete VAERS report online
2021-08-04 Successful
2021-08-17
Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 2 — day 7, dose 1

2021-01-22

Systemic reaction (other): Rash more like Hives

Release 8 — 3 months, dose 2

2021-05-05

Symptoms: Developed a rash 7 days after 2nd shot and still have recurring problems. Dermatologist is stumped. Using multiple steroid creams and Dupixant shots.
Healthcare visit (other): Bi-weekly dermatology office visits

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: Continued accurate dermatitis as allergic reaction to the Pfizer shot in February. Still severe raw blisters appearing on both hands and uncontrollable rash in legs. Dermatologist is baffled as to how to treat.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDBlister ✓ · ✓
SDDermatitis ✓ · ✓
SDHypersensitivity ✓ · ✓
SDOffice visit ✓ · ✓
SDRash ✓ ✓ ✓
SROUrticaria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release